GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood sugar tracking may extend life in brain cancer patients
Disease control Recruiting nowThis study tests whether a continuous glucose monitor (CGM) can help people with glioblastoma, a serious brain cancer, manage their blood sugar levels and potentially live longer. High blood sugar is common in these patients due to steroid use and is linked to worse outcomes. The…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 04:29 UTC
-
Diabetes drug shows promise against deadly brain tumor
Disease control Recruiting nowThis study tests whether adding metformin, a common diabetes drug, to standard radiation and chemotherapy can help people with a specific type of glioblastoma (a fast-growing brain cancer). The trial includes about 64 adults whose tumors have a unique energy profile. The goal is …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Hopital Foch • Aim: Disease control
Last updated May 26, 2026 04:27 UTC
-
Radioactive therapy targets hard-to-treat brain tumors in early trial
Disease control Recruiting nowThis early-phase study tests whether a radioactive drug called 177Lu-PSMA-617 is safe for people with a fast-growing type of brain cancer (IDH wild type glioma). About 20 adults whose tumors express a protein called PSMA will receive the drug after standard treatments. The main g…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New pill shows promise for Hard-to-Treat brain cancers
Disease control Recruiting nowThis study tests an experimental oral drug called NEO212 in adults with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it can slow tumor growth. About 134 participants will receive NEO212 a…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy aims to outsmart deadly brain cancer
Disease control Recruiting nowThis study tests whether adding the drug WP1066 to standard radiation therapy can help people with a newly diagnosed, aggressive brain cancer called glioblastoma. The drug targets a protein that helps the tumor grow and hide from the immune system. About 39 adults will take part …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New hope for aggressive brain tumors: drug combo shows promise before surgery
Disease control Recruiting nowThis study tests two drugs, GI-102 and pembrolizumab, given before surgery to people whose aggressive brain cancer (glioblastoma) has returned. The goal is to see if these drugs can shrink the tumor and help the immune system fight the cancer. About 36 adults will take part, and …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Promising new combo may extend life in aggressive brain cancer
Disease control Recruiting nowThis study tests whether adding another chemotherapy drug (lomustine) to the standard treatment can help people with a specific type of glioblastoma, a fast-growing brain cancer, live longer. About 200 adults aged 18-70 with newly diagnosed, MGMT-methylated glioblastoma will be r…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Brain tumor imaging trial aims to decode MRI mysteries
Knowledge-focused Recruiting nowThis study is for 100 adults with newly diagnosed glioblastoma. It tests if special MRI and PET scans can tell the difference between tumor growth and harmless changes caused by treatment. The goal is to improve how doctors read scans and make treatment decisions.
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC